Cleared Traditional

K910873 - BD ANGIOGRAPHIC SYRINGE W/A ROTATING TIP

K910873 is an FDA 510(k) clearance for BD ANGIOGRAPHIC SYRINGE W/A ROTATING TIP, manufactured by Bd Becton Dickinson Vacutainer Systems Preanalytic. The device is a Class 2 Cardiovascular device with product code DXT cleared through the Traditional 510(k) pathway after a 89-day FDA review.

K910873 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1991
Decision
89d
Days
Class 2
Risk

K910873 is an FDA 510(k) clearance for the BD ANGIOGRAPHIC SYRINGE W/A ROTATING TIP. Classified as Injector And Syringe, Angiographic (product code DXT), Class II - Special Controls.

Submitted by Bd Becton Dickinson Vacutainer Systems Preanalytic (Franklin Lakes, US). The FDA issued a Cleared decision on May 29, 1991 after a review of 89 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1650 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bd Becton Dickinson Vacutainer Systems Preanalytic devices

FDA 510(k) Submission Details - K910873

510(k) Number K910873 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 01, 1991
Decision Date May 29, 1991
Days to Decision 89 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
36d faster than avg
Panel avg: 125d · This submission: 89d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXT Device Classification - Class 2, Special Controls

Product Code DXT Injector And Syringe, Angiographic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1650
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXT Injector And Syringe, Angiographic

All 174
Devices cleared under the same product code (DXT) and FDA review panel - the closest regulatory comparables to K910873.
CT 8000 DIGITAL INJECTION SYSTEM
K912944 · Mallinckrodt Group, Inc. · Feb 1992
TRAC-WRIGHT SYSTEM, MODEL TW2
K910594 · Dow Corning Wright · Sep 1991
MEDRAD VARIBLE INFUSION INJECTOR
K905819 · Medrad, Inc. · Sep 1991
CLOSED SYSTEM FLUSH SET
K904994 · Argon Medical Corp. · Jan 1991
HIGH-PRESSURE CONNECTOR TUBE
K904212 · Mallinckrodt Medical · Dec 1990
MAINTENACE FLOW - ACCESORY DEVICE FOR CAVROPUMP
K903494 · Life-Tech Intl., Inc. · Oct 1990